COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA. Voprosy onkologii, v. 66, n. 2, p. 109–119, 1 Feb.2020.